Last reviewed · How we verify
Pathogen-Reduced Platelet Concentrates — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Pathogen-Reduced Platelet Concentrates (Pathogen-Reduced Platelet Concentrates) — Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pathogen-Reduced Platelet Concentrates TARGET | Pathogen-Reduced Platelet Concentrates | Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pathogen-Reduced Platelet Concentrates CI watch — RSS
- Pathogen-Reduced Platelet Concentrates CI watch — Atom
- Pathogen-Reduced Platelet Concentrates CI watch — JSON
- Pathogen-Reduced Platelet Concentrates alone — RSS
Cite this brief
Drug Landscape (2026). Pathogen-Reduced Platelet Concentrates — Competitive Intelligence Brief. https://druglandscape.com/ci/pathogen-reduced-platelet-concentrates. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing